KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Resmed (RMD) Other Gross PP&E Adjustments (2016 - 2025)

Historic Other Gross PP&E Adjustments for Resmed (RMD) over the last 16 years, with Q4 2025 value amounting to $1.1 billion.

  • Resmed's Other Gross PP&E Adjustments rose 780.29% to $1.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.1 billion, marking a year-over-year increase of 780.29%. This contributed to the annual value of $1.1 billion for FY2025, which is 328.0% down from last year.
  • Latest data reveals that Resmed reported Other Gross PP&E Adjustments of $1.1 billion as of Q4 2025, which was up 780.29% from $1.1 billion recorded in Q3 2025.
  • In the past 5 years, Resmed's Other Gross PP&E Adjustments registered a high of $1.2 billion during Q3 2024, and its lowest value of $927.2 million during Q1 2021.
  • Moreover, its 5-year median value for Other Gross PP&E Adjustments was $1.1 billion (2022), whereas its average is $1.1 billion.
  • In the last 5 years, Resmed's Other Gross PP&E Adjustments surged by 1933.37% in 2021 and then plummeted by 443.13% in 2024.
  • Resmed's Other Gross PP&E Adjustments (Quarter) stood at $965.4 million in 2021, then grew by 11.04% to $1.1 billion in 2022, then rose by 3.8% to $1.1 billion in 2023, then decreased by 4.43% to $1.1 billion in 2024, then grew by 7.8% to $1.1 billion in 2025.
  • Its Other Gross PP&E Adjustments stands at $1.1 billion for Q4 2025, versus $1.1 billion for Q3 2025 and $1.1 billion for Q2 2025.